drugset
Drugs / chitosan nanoparticles
last change Sep 2025 re-read 2 minutes ago

chitosan nanoparticles

also known as CS-np

Other / unclassified

Developed for
dental pulp necrosis · periodontitis
Investigated by
Ain Shams University · Cairo University

Trials 2 · a red edge is where a trial was stopped

today NCT03719261 · Ph 2/3 NCT03588351 · not/applicable
201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/31 trial
Phase 2/3 NCT03719261 Nov 2018 → Apr 2019 — Cairo University Unknown No outcome recorded
Phase not applicable1 trial
— NCT03588351 Jan → Aug 2018 dental pulp necrosis Ain Shams University Unknown No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT06777303 Comparator Jun 2024 → Aug 2025 overdue periodontitis Mansoura University Active not recruiting No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as chitosan nanoparticles ClinicalTrials.gov intervention name — accepted as the source's own label NCT03588351 ↗
2

NCT06777303 ↗

NCT03719261 ↗
Known as CS-np “A randomized clinical trial that aims to study the effect of chitosan nanoparticles (CS-np) versus sodium hypochlorite as a root canal irrigant on postoperative pain and...” NCT03719261 ↗
Modality Other / unclassified “Chitosan nanoparticle is a bioactive and environment friendly material with unique physicochemical properties .” NCT03588351 ↗
Route Other “chitosan nanoparticles that ready to use as intracanal medicament.” NCT03588351 ↗